AVCR Stock Overview
Engages in the health data and point-of-care technologies business in Canada.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
Avricore Health Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.13 |
52 Week High | CA$0.34 |
52 Week Low | CA$0.10 |
Beta | -1.88 |
11 Month Change | -34.21% |
3 Month Change | -52.83% |
1 Year Change | -28.57% |
33 Year Change | -13.79% |
5 Year Change | 525.00% |
Change since IPO | -99.18% |
Recent News & Updates
Recent updates
Shareholder Returns
AVCR | CA Healthcare Services | CA Market | |
---|---|---|---|
7D | -16.7% | 5.0% | 0.2% |
1Y | -28.6% | 107.1% | 24.4% |
Return vs Industry: AVCR underperformed the Canadian Healthcare Services industry which returned 109.5% over the past year.
Return vs Market: AVCR underperformed the Canadian Market which returned 23.2% over the past year.
Price Volatility
AVCR volatility | |
---|---|
AVCR Average Weekly Movement | 10.1% |
Healthcare Services Industry Average Movement | 10.1% |
Market Average Movement | 8.2% |
10% most volatile stocks in CA Market | 17.6% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: AVCR has not had significant price volatility in the past 3 months compared to the Canadian market.
Volatility Over Time: AVCR's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | n/a | Hector Bremner | avricore.com |
Avricore Health Inc. engages in the health data and point-of-care technologies business in Canada. It provides HealthTab, a turnkey point-of-care testing platform that turns pharmacies into community point-of-care diagnostic centers. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018.
Avricore Health Inc. Fundamentals Summary
AVCR fundamental statistics | |
---|---|
Market cap | CA$14.13m |
Earnings (TTM) | -CA$2.92k |
Revenue (TTM) | CA$4.48m |
2.8x
P/S Ratio-4,323x
P/E RatioIs AVCR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AVCR income statement (TTM) | |
---|---|
Revenue | CA$4.48m |
Cost of Revenue | CA$2.86m |
Gross Profit | CA$1.62m |
Other Expenses | CA$1.62m |
Earnings | -CA$2.92k |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.000029 |
Gross Margin | 36.16% |
Net Profit Margin | -0.065% |
Debt/Equity Ratio | 0% |
How did AVCR perform over the long term?
See historical performance and comparison